CDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine Trial Parthika Patel27 Jun 2025 10:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has reviewed a...
Novavax to sell Bohumil manufacturing facility to Novo Nordisk for USD 200 million Ruchika Sharma4 Dec 2024 4:56 PM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced that it has signed a...
USFDA removes clinical hold on Novavax COVID Influenza combination, stand alone Influenza Phase 3 trial Ruchika Sharma12 Nov 2024 11:00 AM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that the U.S. Food and...
Novavax faces setback as USFDA halts COVID-Flu vaccine trial over nerve damage report MD Bureau17 Oct 2024 3:13 PM ISTNovavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor neuropathy.
EU gives marketing authorization for Novavax updated 2024-2025 Nuvaxovid COVID vaccine Ruchika Sharma11 Oct 2024 10:00 AM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that the European...
FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain MD Bureau Team1 Sept 2024 10:45 AM ISTBengaluru: The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID...
SII high efficacy malaria vaccine launched in Africa Ruchika Sharma16 July 2024 5:03 PM ISTNew Delhi: A new vaccine for malaria jointly developed by the Serum Institute of India (SII) and the University of Oxford was officially...
SII ships first set of R21/Matrix-M Malaria Vaccine doses to Africa Ruchika Sharma21 May 2024 12:30 PM ISTPune: Serum Institute of India, the world's largest manufacturer of vaccines by number of doses, on Monday shipped its first set of R21/Matrix-M...
Sanofi, Novavax ink pact to co-commercialize COVID vaccine, develop novel flu-COVID combination vaccines Ruchika Sharma12 May 2024 10:00 AM ISTParis: Sanofi has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US to develop...
COVID vaccine maker Novavax erases doubts about its ability to remain in business Ruchika Sharma11 May 2024 6:05 PM ISTNovavax, the manufacturer of a COVID-19 vaccine, has dispelled uncertainties about its business continuity by rescinding a "going concern" notice.In...
Novavax settles dispute with Gavi Ruchika Sharma23 Feb 2024 11:30 AM ISTNovavax has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over...
Novavax updated COVID vaccine gets Emergency Use Listing from WHO Ruchika Sharma30 Nov 2023 11:30 AM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that Nuvaxovid XBB.1.5...
